| |
CS (N = 24)
|
ID (N = 31)
|
ND (N = 9)
|
SB (N = 28)
| |
|---|
| |
Number (%)
|
Number (%)
|
Number (%)
|
Number (%)
|
p
|
|---|
|
EEG abnormalities
|
3/24 (12.5 %)
|
2/31 (6.5 %)
|
2/9 (22.2 %)
|
2/28 (7.1 %)
|
=0.495
|
|
History of gastrointestinal disorders
|
13/24 (54.2 %)
|
18/31 (58.1 %)
|
5/9 (55.6 %)
|
7/28 (25.0 %)
|
<0.05
|
|
History of allergies
|
14/24 (58.3 %)
|
15/31 (48.4 %)
|
1/9 (11.1 %)
|
6/28 (21.4 %)
|
<0.01
|
|
History of sleep disorders
|
12/24 (50.0 %)
|
9/31 (29.0 %)
|
3/9 (33.3 %)
|
3/28 (10.7 %)
|
<0.05
|
|
Prenatal, perinatak or postnatal complications
|
8/24 (33.3 %)
|
25/31 (80.6 %)
|
4/9 (44.4 %)
|
8/28 (28.6 %)
|
<0.001
|
|
Macrocrania
|
1/24 (4.2 %)
|
7/31 (22.6 %)
|
3/9 (33.3 %)
|
4/28 (14.3 %)
|
=0.107
|
|
History of regression
|
8/24 (33.3 %)
|
5/31 (16.1 %)
|
4/9 (44.4 %)
|
6/28 (21.4 %)
|
=0.243
|
|
Family history of psycho-neurological disorders
|
16/24 (66.7 %)
|
17/31 (54.8 %)
|
3/9 (33.3 %)
|
16/28 (57.1 %)
|
=0.399
|
|
Family history of tumors
|
3/24 (12.5 %)
|
5/31 (16.1 %)
|
2/9 (22.2 %)
|
3/28 (10.7 %)
|
=0.817
|
-
CS Circadian and sensory dysfunction subgroup, ID Immune dysfunction subgroup, ND Neurodevelopmental delay subgroup, SB Stereotypic behaviour subgroup; Statistically significant results are in bold
